Neurointerventional Device Market Outlook from (2023 to 2033)
The neurointerventional Device market size is projected to be worth US$ 2.6 billion in 2023. The market is likely to reach US$ 4.1 billion by 2033. The market is further expected to surge at a CAGR of 4.7% during the forecast period 2023 to 2033.
Key Market Trends and Highlights
Emerging economies are witnessing increased healthcare spending and improved healthcare infrastructure, which is expected to create new opportunities for neurointerventional device manufacturers.
Advancements in precision medicine are allowing for more personalized treatment plans, which can include the use of specific neurointerventional Device tailored to individual patients' needs.
AI and machine learning are being used to enhance the accuracy of diagnostics and treatment planning in neurointerventional procedures, which can improve patient outcomes.
Neurointerventional Device Market Estimated Size in 2023
US$ 2.6 billion
Projected Market Value in 2033
US$ 4.1 billion
Value-based CAGR from 2023 to 2033
4.7%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2018 to 2022 Historical Analysis vs. 2023 to 2033 Market Forecast Projections
The scope for neurointerventional Device rose at a 4.3% CAGR between 2018 and 2022. The global market for neurointerventional Device is anticipated to grow at a moderate CAGR of 4.7% over the forecast period 2023 to 2033.
Report Attributes
Details
Market Value in 2018
US$ 2.1 billion
Market Value in 2022
US$ 2.5 billion
CAGR from 2018 to 2022
4.3%
According to the World Health Organization (WHO), neurological disorders are the leading cause of disability worldwide. The prevalence of neurological disorders is expected to increase in the coming years due to aging population and increasing risk factors, such as hypertension, diabetes, and obesity.
Neurointerventional Device offer minimally invasive treatments for neurological disorders, which are associated with shorter hospital stays, faster recovery times, and fewer complications, which is driving the demand for neurointerventional Device.
Technological advancements in neurointerventional Device, such as the development of new Device with improved performance and safety, are also driving the growth of the market. Neurointerventional Device are being increasingly used to treat a wider range of neurological disorders, such as chronic cerebrospinal fluid (CSF) leaks and brain tumors, which is expanding the market for neurointerventional Device.
The Asia Pacific region is expected to be the fastest-growing market for neurointerventional Device during the forecast period. The growth of the neurointerventional Device market in Asia Pacific is attributed to the increasing prevalence of neurological disorders in the region, as well as the growing demand for minimally invasive treatments.
Neurointerventional Device Market Key Drivers
An aging population is more prone to neurological conditions and disorders, which increases the demand for neurointerventional Device. As the global population continues to age, this trend is expected to drive market growth.
Advances in neurointerventional Device and techniques, such as minimally invasive procedures and the development of new materials, have improved the effectiveness and safety of treatments, which encourages both patients and healthcare providers to opt for these Device.
The prevalence of neurological disorders like stroke, aneurysms, and Alzheimer's disease is on the rise. Neurointerventional Device play a crucial role in diagnosis, treatment, and management of these conditions.
Growing awareness about the availability of minimally invasive treatments for neurovascular conditions is leading to early diagnosis and intervention, thereby driving the market's growth.
Find your sweet spots for generating winning opportunities in this market.
Challenges in the Neurointerventional Device Market
Neurointerventional Device often require rigorous regulatory approvals and clinical trials due to the critical nature of neurological procedures. Delays or rejections in obtaining regulatory clearance can slow down market entry and product adoption.
Neurointerventional Device are often expensive, and the high cost can be a barrier, especially in regions with limited healthcare budgets or where patients may have limited access to advanced healthcare.
In many regions, access to specialized neurointerventional care may be limited, leading to underutilization of neurointerventional Device and procedures.
Neurointerventional procedures require a high level of expertise. A shortage of skilled neurointerventional radiologists and neurosurgeons can limit the growth of the market.
Comparative View of Adjacent Markets
Future Market Insights has compared two other markets, namely Minimally Invasive Neurosurgery Device and Brain Monitoring Systems Market below. This showcases that Neurointerventional Device industry is set to dominate out of these three markets over the forecast period 2023 to 2033.
The establishment of training programs and centers of excellence in neurointerventional radiology can help train more healthcare professionals in using these Device effectively.
Neurointerventional Device Market:
CAGR from 2023 to 2033
4.7%
Market Value in 2033
US$ 4.1 billion
Key Trends
With the increasing use of digital health records and remote monitoring, there are opportunities for companies to develop neurointerventional Device that prioritize data security and patient privacy.
Companies in the neurointerventional device market may explore opportunities for expansion in emerging markets and diversify their product portfolios to meet a broader range of clinical needs.
Opportunity
Healthcare providers are increasingly emphasizing patient outcomes and quality of life, which may drive the adoption of neurointerventional Device that offer better results and fewer complications.
Growing awareness of environmental concerns may drive the development of eco-friendly materials and manufacturing processes for neurointerventional Device.
Minimally Invasive Neurosurgery Device Market:
CAGR from 2023 to 2033
6.3%
Market Value in 2033
US$ 5.9 billion
Key Trends
Continuous technological advancements in imaging, navigation, and surgical instruments have enabled neurosurgeons to perform minimally invasive procedures with greater precision and safety, driving the demand for these Device.
Minimally invasive procedures often result in fewer complications, shorter hospital stays, and faster patient recovery. The patient-centric approach is likely to encourage the adoption of minimally invasive neurosurgery Device.
Opportunity
The increasing incidence of neurological disorders, such as brain tumors, epilepsy, and movement disorders, is driving the demand for effective and less invasive treatment options, spurring market growth.
Patients increasingly prefer minimally invasive surgeries due to reduced pain, smaller incisions, and shorter recovery times. The demand can drive the adoption of minimally invasive neurosurgery Device.
Brain Monitoring Systems Market:
CAGR from 2023 to 2033
5.5%
Market Value in 2033
US$ 8.5 billion
Key Trends
The increasing prevalence of neurological conditions such as epilepsy, Alzheimer's disease, and Parkinson's disease is driving the demand for brain monitoring systems for early diagnosis and treatment.
Ongoing advancements in neuroimaging, electroencephalography (EEG), and other monitoring technologies have improved the accuracy and accessibility of brain monitoring, making it more widely available and driving market growth.
Opportunity
Brain monitoring systems are essential in ICUs for patients with traumatic brain injuries, strokes, or other critical conditions, contributing to their increasing use.
The integration of brain monitoring systems with telemedicine and remote monitoring solutions allows healthcare providers to monitor patients' brain activity from a distance, improving access to care and enhancing the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Insights
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and China. These two countries are expected to lead the market through 2033.
Forecast CAGRs from 2023 to 2033
The United States
4.6%
China
4.6%
India
4.5%
Japan
4.3%
Germany
4.0%
Increasing Prevalence of Neurological Disorders Driving the United States Market
The neurointerventional Device market in the United States is expected to expand at a CAGR of 4.6% through 2033. The United States has a significant population affected by neurological disorders, including strokes, aneurysms, and brain tumors.
The rising incidence of these conditions drives the demand for neurointerventional Device for diagnosis and treatment. There is an increased risk of age-related neurological conditions, with a growing aging population. The demographic trend contributes to the demand for neurointerventional procedures and Device.
The United States is a hub for medical technology innovation. Continuous advancements in imaging, navigation, and interventional Device enhance the precision and safety of neurointerventional procedures, boosting their adoption.
The United States has a well-developed healthcare infrastructure with advanced hospitals and medical facilities, providing a conducive environment for neurointerventional procedures and the use of associated Device.
Increasing Patient Awareness to Accelerate Market Growth in China
The China’s neurointerventional Device market is anticipated to expand at a CAGR of 4.6% through 2033. China has been increasing its healthcare expenditure to improve healthcare infrastructure and access to advanced medical technologies, including neurointerventional Device.
The Chinese government has been promoting healthcare reforms and investments in medical research and development, supporting the growth of the medical device industry, including neurointerventional Device.
Healthcare reform initiatives aimed at expanding access to quality care and improving patient outcomes are likely to drive the adoption of neurointerventional procedures and Device. Growing patient awareness of neurological conditions and available treatment options, including minimally invasive neurointerventional procedures, can boost demand.
China has been investing in training and education programs for healthcare professionals, including neurosurgeons and interventional neuroradiologists, to perform neurointerventional procedures effectively.
Rising Healthcare Expenditure Fueling the Market in India
The neurointerventional Device market in India is poised to expand at a CAGR of 4.5% through 2033. India has been increasing its healthcare expenditure, with a focus on improving healthcare infrastructure and access to advanced medical technologies, including neurointerventional Device.
Ongoing advancements in medical technology, including imaging, navigation, and minimally invasive Device used in neurointerventional procedures, enhance the accessibility and effectiveness of these treatments.
The Indian government has been promoting healthcare reforms and investments in medical research and development, supporting the growth of the medical device industry, including neurointerventional Device. Healthcare reform initiatives aimed at expanding access to quality care and improving patient outcomes are likely to drive the adoption of neurointerventional procedures and Device.
A growing number of domestic and international medical device companies are entering the Indian market, fostering competition and innovation in the neurointerventional Device sector. The Indian government has been working on streamlining regulatory processes and approvals for medical Device, making it easier for new neurointerventional Device to enter the market.
Government Support Spearheads the Market in Japan
Neurointerventional Device trends in Japan are taking a turn for the better. A 4.3% CAGR is forecast for the country from 2023 to 2033. Japan boasts a highly advanced and well-developed healthcare infrastructure, making it conducive for the adoption of advanced medical technologies, including neurointerventional Device.
The Japanese government has been promoting healthcare reforms and investing in medical research and development, supporting the growth of the medical device industry, including neurointerventional Device.
Japan is known for its commitment to research and development, particularly in the medical field. The country continues to invest in neuroscience research and innovative device development. The integration of telemedicine and remote consultations can improve access to neurointerventional expertise, particularly in remote or underserved areas of Japan.
Skilled Healthcare Workforce Driving the Sales in Germany
The neurointerventional Device market in Germany is anticipated to expand at a CAGR of 4.0% through 2033. Germany has a well-trained and experienced healthcare workforce, including neurosurgeons, interventional neuroradiologists, and specialized clinicians, who are proficient in performing neurointerventional procedures.
Healthcare reform efforts to enhance patient access to quality care and improve patient outcomes are expected to drive the adoption of neurointerventional procedures and Device.
Growing patient awareness of neurological conditions and available treatment options, including minimally invasive neurointerventional procedures, can boost demand. Germany's universal healthcare system ensures that many patients have access to insurance coverage for medical procedures, including neurointerventional treatments.
Category-wise Insights
The below table highlights how neurovascular thrombectomy Device segment is projected to lead the market in terms of product, and is expected to expand at a CAGR of 4.6% through 2033.
The hospitals segment of end-user is likely to spearhead sales, and is expected to expand at a CAGR of 4.5% through 2033.
Category
CAGR (in 2033)
Neurovascular Thrombectomy Device
4.6%
Hospitals
4.5%
Neurovascular Thrombectomy Device Segment Claims High Demand for Neurointerventional Device
Based on product, the neurovascular thrombectomy Device segment is expected to continue dominating the neurointerventional Device industry.
The rising prevalence of ischemic strokes, often caused by blood clots or thrombi in the cerebral vessels, drives the demand for neurovascular thrombectomy Device for clot removal. Ongoing advancements in thrombectomy techniques, including the development of stent retrievers and other minimally invasive Device, improve the effectiveness of clot removal, leading to higher demand.
Neurovascular thrombectomy Device have been shown to significantly improve patient outcomes by reducing disability and mortality rates, making them a preferred treatment option. The expansion of telestroke programs and regional stroke centers increases access to thrombectomy procedures, enhancing the market.
Government initiatives and healthcare policies aimed at reducing the burden of stroke and improving access to thrombectomy procedures support market growth. Ongoing research into new thrombectomy Device and techniques leads to the development of more effective and efficient Device.
Hospitals to Hold High Demand for Neurointerventional Device Industry
Based on end-user, the hospitals segment is expected to continue dominating the neurointerventional Device industry. Hospitals are equipped with advanced imaging facilities, specialized operating rooms, and a skilled medical workforce, making them ideal for performing complex neurointerventional procedures. Neurological conditions often require specialized care from neurosurgeons, interventional neuroradiologists, and neurologists, which is readily available in hospital settings.
Hospitals are primary destinations for emergency neurological cases such as stroke and aneurysm rupture, where timely intervention is critical. Hospitals typically have access to high-quality imaging equipment such as MRI, CT, and angiography machines, which are essential for accurate diagnosis and treatment planning in neurointerventional procedures.
Hospitals can provide comprehensive care by offering a range of services, from diagnosis and treatment to post-procedural care and rehabilitation, promoting patient continuity. Hospitals often engage in clinical research, allowing for the incorporation of the latest neurointerventional Device and techniques into patient care.
Competitive Landscape
The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.
In 2023, Medtronic announced the launch of its new neurointerventional device, the Solitaire™ Prime Revascularization Device. The Solitaire™ Prime Revascularization Device is a next-generation stentriever that is designed to improve the treatment of stroke.
In 2023, Stryker announced the acquisition of Neurovascular Therapies, a leading producer of neurointerventional Device. The acquisition gives Stryker access to Neurovascular Therapies' portfolio of neurointerventional Device, which will allow Stryker to expand its neurointerventional device offerings.
In 2022, Terumo announced the launch of its new neurointerventional device, the Wingspan® Stent System. The Wingspan® Stent System is a self-expanding intracranial stent that is designed to treat stenosis of the intracranial arteries.
Report Scope
Attribute
Details
Estimated Market Size in 2023
US$ 2.6 billion
Projected Market Valuation in 2033
US$ 4.1 billion
Value-based CAGR 2023 to 2033
4.7%
Forecast Period
2023 to 2033
Historical Data Available for
2018 to 2022
Market Analysis
Value in US$ billion
Key Regions Covered
North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East & Africa
Key Market Segments Covered
Product
Technique
End-User
Region
Key Countries Profiled
The United States
Canada
Brazil
Mexico
Germany
France
France
Spain
Italy
Russia
Poland
Czech Republic
Romania
India
Bangladesh
Australia
New Zealand
China
Japan
South Korea
GCC countries
South Africa
Israel
Key Companies Profiled
Stryker Corporation
Penumbra Inc.
Covidien Public Limited
Johnson & Johnson Private Limited
Terumo Corporation
Medtronic
Boston Scientific
MicroPort Scientific Corporation
W. L. Gore & Associates, Inc.
Abbott
Philips Healthcare
Siemens Healthineers
Segmentation Analysis of the Neurointerventional Device Market
By Product:
Embolic Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Embolic Protection Device
Flow Diverters Device
Intrasaccular Device
Liquid Embolic
Balloons
Stent Retrievers
By Technique:
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
By End User:
Hospitals
Ambulatory Surgical Centers
By Region:
North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
The Middle East & Africa
Frequently Asked Questions
What is the expected worth of the Neurointerventional Device market in 2023?
The neurointerventional Device market is expected to reach US$ 2.6 billion in 2023.
What is the expected CAGR for the Neurointerventional Device market until 2033?
The market for neurointerventional Device is set to expand by a CAGR of 4.7% by 2033.
How much valuation is projected for the Neurointerventional Device market in 2033?
The neurointerventional Device industry is forecast to reach US$ 4.1 billion by 2033.
Which country is likely to be at the pinnacle of the Neurointerventional Device market?
The United States is likely to be the top performing market, and to expand at a CAGR of 4.6% through 2033.
Which is the leading product in the Neurointerventional Device domain?
Neurovascular thrombectomy device segment is preferred, and is expected to expand at a CAGR of 4.6% through 2033.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Embolic Coils
5.3.2. Carotid Stents
5.3.3. Intracranial Stents
5.3.4. Neurovascular Thrombectomy
5.3.5. Embolic Protection Devices
5.3.6. Flow Diverters Devices
5.3.7. Intrasaccular Devices
5.3.8. Liquid Embolic
5.3.9. Balloons
5.3.10. Stent Retrievers
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technique
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Technique, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Technique, 2023 to 2033
6.3.1. Neurothrombectomy Procedure
6.3.2. Cerebral Angiography
6.3.3. Stenting
6.3.4. Coiling Procedures
6.3.5. Flow Disruption
6.4. Y-o-Y Growth Trend Analysis By Technique, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Technique, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Technique
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Technique
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Technique
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Technique
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Technique
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Technique
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Technique
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Technique
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Technique
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Technique
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Technique
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Technique
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Technique
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Technique
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Technique
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Technique
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Technique
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Technique
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Technique
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Technique
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Technique
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Technique
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Technique
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Technique
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Technique
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Technique
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Technique
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Technique
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Technique
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Technique
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Technique
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Technique
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Technique
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Technique
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Technique
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product
16.22.2.2. By Technique
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product
16.23.2.2. By Technique
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Technique
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Stryker Corporation
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Penumbra Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Covidien Public Limited
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Johnson & Johnson Private Limited
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Terumo Corporation
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Insera Therapeutics Inc
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Anaconda Biomed S.L.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. NeuroVasc Technologies
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Perflow Medical Ltd.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
19. Assumptions & Acronyms Used20. Research Methodology
